ITCIIntra-Cellular Therapies Inc
Slide 1 of 3 
Company Overview
Name
Intra-Cellular Therapies Inc
52W High
$131.98
52W Low
$64.09
Market Cap
$14B
Dividend Yield
0%
Price/earnings
-0.72
P/E
-0.72
Tags
Biotechnology
Health Technology
Manufacturing
Pharmaceutical Preparation Manufacturing
Dividends
No dividend
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 2 of 3
Income Statement
Total Revenue
$680.9M
Operating Revenue
$680.9M
Total Gross Profit
$623.9M
Total Operating Income
$-116.7M
Net Income
$-74.7M
EV to EBITDA
$0.00
EV to Revenue
$19.12
Price to Book value
$12.21
Price to Earnings
$0.00
Additional Data
Selling, General & Admin Expense
$504.5M
Research & Development Expense
$236.1M
Total Operating Expenses
$-740.6M
Interest & Investment Income
$42.5M
Total Other Income / (Expense), net
$42.5M
Total Pre-Tax Income
$-74.2M
Slide 3 of 3
Earnings History
Estimated EPS
Reported EPS
N/A Slide 1 of 5
Company Overview
Name
Intra-Cellular Therapies Inc
52W High
$131.98
52W Low
$64.09
Market Cap
$14B
Dividend Yield
0%
Price/earnings
-0.72
P/E
-0.72
Tags
Biotechnology
Health Technology
Manufacturing
Pharmaceutical Preparation Manufacturing
Dividends
No dividend
Slide 2 of 5
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 3 of 5
Income Statement
Total Revenue
$680.9M
Operating Revenue
$680.9M
Total Gross Profit
$623.9M
Total Operating Income
$-116.7M
Net Income
$-74.7M
EV to EBITDA
$0.00
EV to Revenue
$19.12
Price to Book value
$12.21
Price to Earnings
$0.00
Slide 4 of 5
Additional Data
Selling, General & Admin Expense
$504.5M
Research & Development Expense
$236.1M
Total Operating Expenses
$-740.6M
Interest & Investment Income
$42.5M
Total Other Income / (Expense), net
$42.5M
Total Pre-Tax Income
$-74.2M
Slide 5 of 5
Earnings History
Estimated EPS
Reported EPS
N/AUpcoming Earnings
We were not able to find an announced earnings date for this symbol yet. Check back again later
Company Info
CEO
Sharon Mates
Location
New Jersey, USA
Exchange
Nasdaq
Website
https://intracellulartherapies.com
Summary
Intra-Cellular Therapies, Inc.
Company Info
CEO
Sharon Mates
Location
New Jersey, USA
Exchange
Nasdaq
Website
https://intracellulartherapies.com
Summary
Intra-Cellular Therapies, Inc.